
Anavex Life Sciences Corp.: updates and filings
Price
$0.59
November 20, 2026Market cap $53M
What Ploutos Investor adds for Anavex Life Sciences
Part of Ploutos Investor, €9.99 a month
- The full history: 17 fiscal years, from FY2009
- The estimated fair value, with its range and its certainty
- The full analysis, 18 a month
- More questions to the chat on its filings
- Excel with every year
- An email when it reports, changes its dividend or an officer buys
Sign in with a free account to see the last 5 fiscal years.
Notes on these figures
- The share price has fallen 80% since Aug 28, 2026, when the 10-Q these figures come from was filed ($2.99 then, $0.59 on Nov 20, 2026). The figures date from before that move.10-Q
- The latest annual figures the company filed are for 2025, more than a year ago. Newer ones may be late.
What comes next, and what happened
Its next results and latest dividend, and the filings that told of something: results, deals, people, debt. In plain words, each linked to the filing.
Next results
last Aug 25, 2026next Nov 12, 2026
An estimate from when it has reported before, and the timing has varied a little. The company announces the date itself.
November 2026
September 2026
August 2026
Its SEC filings
What it has filed lately, newest first, linked to the document itself.
- Nov 3, 2026Officer or director changeForm8-K
- Nov 2, 2026Officer or director change, other material eventsForm8-K
- Oct 20, 2026Other material eventsForm8-K
- Oct 15, 2026Other material eventsForm8-K
- Sep 28, 2026Change in control, shareholder voteForm8-K
- Sep 21, 2026FilingFormDFAN14A
- Sep 18, 2026FilingFormDFAN14A
- Sep 17, 2026FilingFormDFAN14A
- Sep 15, 2026Additional annual meeting materialFormDEFA14A
- Sep 15, 2026FilingFormDFAN14A
- Sep 14, 2026Additional annual meeting materialFormDEFA14A
- Sep 10, 2026FilingFormDFAN14A
- Sep 10, 2026FilingFormDFAN14A
- Sep 9, 2026FilingFormDFAN14A
- Sep 9, 2026Other material eventsForm8-K
- Sep 8, 2026Additional annual meeting materialFormDEFA14A
- Sep 4, 2026Additional annual meeting materialFormDEFA14A
- Sep 4, 2026FilingFormDFAN14A
- Sep 3, 2026FilingFormDFAN14A
- Sep 2, 2026Other material eventsForm8-K
- Sep 2, 2026FilingFormDFAN14A
- Sep 1, 2026Additional annual meeting materialFormDEFA14A
- Aug 31, 2026Additional annual meeting materialFormDEFA14A
- Aug 28, 2026Quarterly reportfor the period to Jun 30, 2026Form10-Q
- Aug 28, 2026Quarterly reportfor the period to Mar 31, 2026Form10-Q
| Filed | Form | What it is | Filing |
|---|---|---|---|
| Nov 3, 2026 | 8-K | Officer or director change | Document |
| Nov 2, 2026 | 8-K | Officer or director change, other material events | Document |
| Oct 20, 2026 | 8-K | Other material events | Document |
| Oct 15, 2026 | 8-K | Other material events | Document |
| Sep 28, 2026 | 8-K | Change in control, shareholder vote | Document |
| Sep 21, 2026 | DFAN14A | Filing | Document |
| Sep 18, 2026 | DFAN14A | Filing | Document |
| Sep 17, 2026 | DFAN14A | Filing | Document |
| Sep 15, 2026 | DEFA14A | Additional annual meeting material | Document |
| Sep 15, 2026 | DFAN14A | Filing | Document |
| Sep 14, 2026 | DEFA14A | Additional annual meeting material | Document |
| Sep 10, 2026 | DFAN14A | Filing | Document |
| Sep 10, 2026 | DFAN14A | Filing | Document |
| Sep 9, 2026 | DFAN14A | Filing | Document |
| Sep 9, 2026 | 8-K | Other material events | Document |
| Sep 8, 2026 | DEFA14A | Additional annual meeting material | Document |
| Sep 4, 2026 | DEFA14A | Additional annual meeting material | Document |
| Sep 4, 2026 | DFAN14A | Filing | Document |
| Sep 3, 2026 | DFAN14A | Filing | Document |
| Sep 2, 2026 | 8-K | Other material events | Document |
| Sep 2, 2026 | DFAN14A | Filing | Document |
| Sep 1, 2026 | DEFA14A | Additional annual meeting material | Document |
| Aug 31, 2026 | DEFA14A | Additional annual meeting material | Document |
| Aug 28, 2026 | 10-Q | Quarterly reportfor the period to Jun 30, 2026 | Document |
| Aug 28, 2026 | 10-Q | Quarterly reportfor the period to Mar 31, 2026 | Document |
From the company's record at the SEC (EDGAR). The topics of each 8-K are the item codes the company itself filed. Its whole record at the SEC, since Jan 13, 2005.
The full analysis
What do Anavex Life Sciences's filings show?
The filings are where every one of Anavex Life Sciences's figures comes from. The full Ploutos AI analysis reads everything the company has filed and shows what stands behind it, with a source for every figure.
- A fair value range built from the filings
- Earnings quality, debt and red flags
- Insider and institutional moves
- The case for and the case against
Related pages
The other pages on US stocks, free to read. On the company pages, the last three fiscal years are open to everyone, five with a free account, and every year with Ploutos Investor.
The figures come from the company's SEC filings and the share price, and describe what it has reported. They are not a score or a fair value.